
New Cancer Trial Saves Woman's Tongue After Two Surgeries
A Pennsylvania mom facing her third tongue cancer surgery in six years joined a groundbreaking clinical trial at MD Anderson that saved her tongue and her quality of life. The trial uses immunotherapy injections to shrink precancerous lesions without surgery.
Jessica Lutterman had already lost 15% of her tongue to two cancer surgeries when doctors told her she needed a third. The Pennsylvania mom couldn't bear to lose more.
After her second oral surgery, Lutterman's tongue was stitched to the floor of her mouth. She couldn't read aloud to her young children or call out to them at the playground. She lived on smoothies for months while learning to speak again without touching her tongue to the roof of her mouth.
When local oncologists recommended another surgery in spring 2025, she searched for alternatives. She and her husband discovered a clinical trial at UT MD Anderson led by Dr. Moran Amit that could change everything.
The trial tested whether immunotherapy injections applied directly to precancerous lesions could shrink them without surgery. It was available only at MD Anderson, and Lutterman qualified immediately.

Dr. Amit understood her desire to preserve her tongue for as long as possible. He made no promises but offered genuine hope for maintaining her quality of life. His approach combined exceptional skill with warmth and humor that put Lutterman at ease.
The trial represents a breakthrough in preserving function and dignity for oral cancer patients. Traditional surgery remains the standard of care, but this research explores whether targeted immunotherapy can offer similar results without the devastating side effects.
Why This Inspires
Lutterman's story shows how medical innovation can restore not just health but the precious everyday moments we take for granted. Being able to read bedtime stories to your children or share a family meal isn't just quality of life. It's life itself.
Her willingness to support Dr. Amit's research ensures future patients might avoid the painful recoveries she endured. Clinical trials like this one push medicine beyond simply saving lives to saving the experiences that make life worth living.
Now Lutterman advocates for research that prioritizes both survival and the ability to live fully. She knows firsthand that the most meaningful medical breakthroughs often preserve the small joys that matter most.
More Images




Based on reporting by Google News - Cancer Survivor
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


